FGFR3 and colorectal carcinoma: Considering persistent nature of cancer, we assume that modified binding of H4R3me2s and H3R8me2s at the promoters of eIF4E and FGFR3 may persistently influence oncogene expression in CRC and maintain oncogene-induced tumorigenicity.